Please login to the form below

Not currently logged in


This page shows the latest Acquisition news and features for those working in and with pharma, biotech and healthcare.

Astellas to acquire Iveric Bio for approximately $5.9bn

Astellas to acquire Iveric Bio for approximately $5.9bn

The acquisition will grant Astellas access to the US drugmaker’s lead asset, Zimura (avacincaptad pegol), which was recently filed for approval in the US to treat geographic atrophy (GA) secondary ... We believe that this acquisition will enable us to

Latest news

More from news
Approximately 203 fully matching, plus 1,343 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 75 fully matching, plus 101 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 124 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 15 fully matching, plus 133 partially matching documents found.

Subscribe to our email news alerts


Add my company

Hello. We are the Total Health creative agency. It’s our collective mix of talent that gets us to truly different...

Latest intelligence

Tuberculosis – why it remains a major global public health challenge
Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
Whitepaper: Closing the gap with compelling healthcare communications
Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
Healing the Healers
Because if we do not heal the healers, who is going to heal us?...